(Q38980782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Ze Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Min Xiong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yan Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nan Bai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yunping Luo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Luyuan Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yuquan Wei

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yanhua Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Xiaoyue Tan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Rong Xiang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

English

0 references

publication date

27 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

4280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ncomms5280

21 March 2020

exact match

0 references

cites work

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Drug penetration in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Supramolecular drug-delivery systems based on polymeric core-shell architectures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Polymer nanocompartments in broad-spectrum medical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Progress in microRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Cell-penetrating peptides: breaking through to the other side

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

The tumor microenvironment: a target for combination therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Targeting tumor-associated macrophages as a novel strategy against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Asparagine endopeptidase is required for normal kidney physiology and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Effects of legumain as a potential prognostic factor on gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Functional imaging of legumain in cancer using a new quenched activity-based probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

The legumain protease-activated auristatin prodrugs suppress tumor growth and metastasis without toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Current trends in the use of liposomes for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Cationic TAT peptide transduction domain enters cells by macropinocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

Design and synthesis of novel functional lipid-based bioconjugates for drug delivery and other applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

inferred from DOI database lookup

7 January 2021

based on heuristic

Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCOMMS5280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 March 2020

ADS bibcode

2014NatCo...5.4280L

0 references

1038857601

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json